CN1015542B — (R)-α-乙基-2-氧代-1-吡咯烷乙酰胺的制备方法
Assigned to UCB SA · Expires 1992-02-19 · 34y expired
What this patent protects
本发明涉及(R)-α-乙基-2-氧化-1-吡咯烷乙酰胺的制备方法。该化合物可用(R)-α-乙基-2-氧代-1-吡咯烷乙酸和卤代甲酸烷基酯反应,再与氨反应制得。或将式(A)的(R)-2-氨基-丁酰胺环化制得。式中X为ZOOC-时,Y是-CH 2 -,X为HalCH 2 -时,Y是-CO-。Z为C 1-4 烷基Hal是卤原子。该右旋对映体较之相应的外消旋体记忆效能高,毒性低。 X-CH 2 CH 2 -Y-NHCH(C 2 H 5 )CONH 2 ----(A)
USPTO Abstract
本发明涉及(R)-α-乙基-2-氧化-1-吡咯烷乙酰胺的制备方法。该化合物可用(R)-α-乙基-2-氧代-1-吡咯烷乙酸和卤代甲酸烷基酯反应,再与氨反应制得。或将式(A)的(R)-2-氨基-丁酰胺环化制得。式中X为ZOOC-时,Y是-CH 2 -,X为HalCH 2 -时,Y是-CO-。Z为C 1-4 烷基Hal是卤原子。该右旋对映体较之相应的外消旋体记忆效能高,毒性低。 X-CH 2 CH 2 -Y-NHCH(C 2 H 5 )CONH 2 ----(A)
Drugs covered by this patent
- Briviact (BRIVARACETAM) · UCB
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.